Effectiveness of Empower-Grief for Relatives of Palliative Care Patients: Protocol for an Exploratory Randomized Controlled Trial.

Q2 Psychology
Clinical Psychology in Europe Pub Date : 2025-02-28 eCollection Date: 2025-02-01 DOI:10.32872/cpe.14307
David D Neto, Alexandra Coelho, Sara Albuquerque, Ana Nunes da Silva
{"title":"Effectiveness of Empower-Grief for Relatives of Palliative Care Patients: Protocol for an Exploratory Randomized Controlled Trial.","authors":"David D Neto, Alexandra Coelho, Sara Albuquerque, Ana Nunes da Silva","doi":"10.32872/cpe.14307","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Grief reactions of relatives of palliative care patients are seldom addressed. Most interventions focus on Prolonged Grief Disorder (PGD) and not on its prevention. This is particularly relevant in palliative care, in which death is the result of a difficult period of a terminal illness, making caregivers particularly vulnerable to psychological distress. The purpose of the present exploratory trial is to test the efficacy of a selective intervention (Empower-Grief) for the initial problematic grief reactions and to study potential predictors of adherence and efficacy.</p><p><strong>Method: </strong>This is an exploratory Randomized Controlled Trial (RCT) studying Empower-Grief compared with Treatment as Usual (TAU). Participants will be relatives or caregivers of palliative and oncological patients with initial indicators of risk of developing PGD and will be randomly allocated to Empower-Grief and TAU. Participants will be assessed prior, at the end and six months after the intervention. The primary outcome considered will be symptoms of PGD. The assessment includes measures of anxiety and depression, coping, attachment, psychological flexibility, posttraumatic growth, social support and therapeutic alliance.</p><p><strong>Results: </strong>The trial is ongoing. Forty-four participants will be invited to participate.</p><p><strong>Conclusion: </strong>This study addresses the need for the development of empirically grounded and feasible interventions aimed at dealing with initial problematic reactions in grief, exploring potential predictors and possible venues for personalizing intervention and understanding the mechanism through which these interventions operate.</p>","PeriodicalId":34029,"journal":{"name":"Clinical Psychology in Europe","volume":"7 1","pages":"e14307"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11960559/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Psychology in Europe","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32872/cpe.14307","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Psychology","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Grief reactions of relatives of palliative care patients are seldom addressed. Most interventions focus on Prolonged Grief Disorder (PGD) and not on its prevention. This is particularly relevant in palliative care, in which death is the result of a difficult period of a terminal illness, making caregivers particularly vulnerable to psychological distress. The purpose of the present exploratory trial is to test the efficacy of a selective intervention (Empower-Grief) for the initial problematic grief reactions and to study potential predictors of adherence and efficacy.

Method: This is an exploratory Randomized Controlled Trial (RCT) studying Empower-Grief compared with Treatment as Usual (TAU). Participants will be relatives or caregivers of palliative and oncological patients with initial indicators of risk of developing PGD and will be randomly allocated to Empower-Grief and TAU. Participants will be assessed prior, at the end and six months after the intervention. The primary outcome considered will be symptoms of PGD. The assessment includes measures of anxiety and depression, coping, attachment, psychological flexibility, posttraumatic growth, social support and therapeutic alliance.

Results: The trial is ongoing. Forty-four participants will be invited to participate.

Conclusion: This study addresses the need for the development of empirically grounded and feasible interventions aimed at dealing with initial problematic reactions in grief, exploring potential predictors and possible venues for personalizing intervention and understanding the mechanism through which these interventions operate.

授权悲伤对姑息治疗患者亲属的有效性:一项探索性随机对照试验方案。
背景:姑息治疗患者亲属的悲伤反应很少被提及。大多数干预措施的重点是延长悲伤障碍(PGD),而不是它的预防。这在姑息治疗中尤其重要,因为在这种情况下,死亡是绝症患者经历一段困难时期的结果,使护理人员特别容易受到心理困扰。本探索性试验的目的是测试选择性干预(授权-悲伤)对最初的问题悲伤反应的疗效,并研究依从性和疗效的潜在预测因素。方法:这是一项探索性随机对照试验(RCT),研究授权-悲伤与常规治疗(TAU)的比较。参与者将是具有PGD初始风险指标的姑息治疗和肿瘤患者的亲属或照顾者,并将随机分配到赋权-悲伤和TAU组。参与者将在干预前、干预结束时和干预后六个月接受评估。考虑的主要结果将是PGD的症状。评估包括焦虑和抑郁、应对、依恋、心理灵活性、创伤后成长、社会支持和治疗联盟。结果:试验正在进行中。将邀请44位参与者参加。结论:本研究解决了开发基于经验的可行干预措施的需求,旨在处理悲伤中最初的问题反应,探索潜在的预测因素和个性化干预的可能场所,并了解这些干预措施的运作机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Psychology in Europe
Clinical Psychology in Europe Psychology-Clinical Psychology
CiteScore
3.00
自引率
0.00%
发文量
26
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信